Original Research

Published on 23 Aug 2022

Is ICI-based therapy better than chemotherapy for metastatic NSCLC patients who develop EGFR-TKI resistance? A real-world investigation

in Thoracic Oncology

Yajie Cheng
Bin Yang
Wen Ouyang
Chen Jie
Wei Zhang
Gang Chen
Junhong Zhang
Jing Yu
Conghua Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.920047

3,558 views
8 citations

Original Research

Published on 23 Aug 2022

Microwave ablation therapy assisted by artificial pneumothorax and artificial hydrothorax for lung cancer adjacent to the vital organs

in Thoracic Oncology

Jian Chen
Liqin Qi
Jin Chen
Qingfeng Lin
Yuan Yan
Jie Chen
Zhengyu Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.981789

2,135 views
1 citation

Original Research

Published on 23 Aug 2022

Application of a combined radiomics nomogram based on CE-CT in the preoperative prediction of thymomas risk categorization

in Thoracic Oncology

Wentao Dong
Situ Xiong
Pinggui Lei
Xiaolian Wang
Hao Liu
Yangchun Liu
Huachun Zou
Bing Fan
Yingying Qiu

Frontiers in Oncology

doi 10.3389/fonc.2022.944005

2,247 views
8 citations

Original Research

Published on 23 Aug 2022

Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma

in Thoracic Oncology

Huahang Lin
Ke Zhou
Zhiyu Peng
Linchuan Liang
Jie Cao
Jiandong Mei

Frontiers in Oncology

doi 10.3389/fonc.2022.965727

1,445 views
6 citations

Original Research

Published on 22 Aug 2022

Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma

in Thoracic Oncology

Krishnendu Pal
Tabish Hussain
Hao Xie
Shenduo Li
Ping Yang
Aaron Mansfield
Yanyan Lou
Shantanu Chowdhury
Debabrata Mukhopadhyay

Frontiers in Oncology

doi 10.3389/fonc.2022.959500

1,930 views
1 citation

Systematic Review

Published on 22 Aug 2022

Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis

in Thoracic Oncology

Ke Zhou
Jie Cao
Huahang Lin
Linchuan Liang
Zhongzhong Shen
Lei Wang
Zhiyu Peng
Jiandong Mei

Frontiers in Oncology

doi 10.3389/fonc.2022.962173

4,395 views
20 citations

Original Research

Published on 22 Aug 2022

Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety

in Thoracic Oncology

Hong-Tao Hu
Xiao-Hui Zhao
Chen-Yang Guo
Quan-Jun Yao
Xiang Geng
Wen-Bo Zhu
Hong-Le Li
Wei-Jun Fan
Hai-Liang Li

Frontiers in Oncology

doi 10.3389/fonc.2022.976777

2,158 views
2 citations

Case Report

Published on 19 Aug 2022

Rapid response to monotherapy with MEK inhibitor trametinib for a lung adenocarcinoma patient harboring primary SDN1-BRAF fusion: A case report and literature review

in Thoracic Oncology

Yang Yu
Min Yu
Yanying Li
Xiaojuan Zhou
Tian Tian
Yijia Du
Zegui Tu
Meijuan Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.945620

4,475 views
11 citations

Original Research

Published on 18 Aug 2022

Establishing a novel model of malignant airway stenosis in rabbit

in Thoracic Oncology

Xiaoxiao Lin
Liqin Zhou
Wanting Zhou
Yuping Li
Xuru Jin
Min Ye
Chengshui Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.959309

1,515 views

Original Research

Published on 18 Aug 2022

Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer

in Thoracic Oncology

Byung-Hee Kang
Xue Li
Jaeman Son
Changhoon Song
Hyun-Cheol Kang
Hak Jae Kim
Hong-Gyun Wu
Joo Ho Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.891221

2,204 views
5 citations

Original Research

Published on 17 Aug 2022

Evolutions in the management of non-small cell lung cancer: A bibliometric study from the 100 most impactful articles in the field

in Thoracic Oncology

Siyuan Chen
Yu Qiao
Juan Chen
Yanan Li
Jianlian Xie
Pengfei Cui
Ziwei Huang
Di Huang
Yiming Gao
Yi Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.939838

5,877 views
6 citations

Original Research

Published on 17 Aug 2022

Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor–a retrospective study of 8 cases

in Thoracic Oncology

Xiao Zhu
Wen-Bang Chen
Fu-Bao Xing
Shao Zhou
Zhen Tang
Xiao-Jun Li
Lei Zhang
Yu-Chen Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.840886

1,757 views
2 citations

Original Research

Published on 17 Aug 2022

Comparison of clinical outcomes between cone beam CT-guided thermal ablation and helical tomotherapy in pulmonary metastases from hepatocellular carcinoma

in Thoracic Oncology

Feihang Wang
Shaonan Fan
Qin Shi
Danyang Zhao
Huiyi Sun
Yav Sothea
Mengfei Wu
Huadan Song
Yi Chen
Jiemin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.947284

1,899 views
2 citations

Original Research

Published on 16 Aug 2022

Analysis of prognosis and treatment decisions for patients with second primary lung cancer following esophageal cancer

in Thoracic Oncology

Jin-luan Li
Hui Li
Qian Wu
Han Zhou
Yi Li
Yong-heng Li
Jiancheng Li

Frontiers in Oncology

doi 10.3389/fonc.2022.777934

2,464 views
2 citations

Original Research

Published on 16 Aug 2022

Adjuvant chemotherapy can benefit the survival of stage I lung adenocarcinoma patients with tumour spread through air spaces after resection: Propensity-score matched analysis

in Thoracic Oncology

Shaonan Xie
Qingyi Liu
Yaqing Han
Shize Wang
Huiyan Deng
Guangjie Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.905958

1,935 views
2 citations

Systematic Review

Published on 16 Aug 2022

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis

in Thoracic Oncology

Fang Yang
Yucai Wang
Lin Tang
Aaron Scott Mansfield
Alex A. Adjei
Konstantinos Leventakos
Narjust Duma
Jia Wei
Lifeng Wang
Baorui Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.955440

6,521 views
5 citations

Navigation group

Articles

Is ICI-based therapy better than chemotherapy for metastatic NSCLC patients who develop EGFR-TKI resistance? A real-world investigation

Microwave ablation therapy assisted by artificial pneumothorax and artificial hydrothorax for lung cancer adjacent to the vital organs

Application of a combined radiomics nomogram based on CE-CT in the preoperative prediction of thymomas risk categorization

Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma

Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma

Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis

Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety

Rapid response to monotherapy with MEK inhibitor trametinib for a lung adenocarcinoma patient harboring primary SDN1-BRAF fusion: A case report and literature review

Establishing a novel model of malignant airway stenosis in rabbit

Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer

Evolutions in the management of non-small cell lung cancer: A bibliometric study from the 100 most impactful articles in the field

Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor–a retrospective study of 8 cases

Comparison of clinical outcomes between cone beam CT-guided thermal ablation and helical tomotherapy in pulmonary metastases from hepatocellular carcinoma

Analysis of prognosis and treatment decisions for patients with second primary lung cancer following esophageal cancer

Adjuvant chemotherapy can benefit the survival of stage I lung adenocarcinoma patients with tumour spread through air spaces after resection: Propensity-score matched analysis

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis